Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CILP anticorps (Internal Region)

CILP Reactivité: Humain, Rat, Souris, Chien WB, EIA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN453982
  • Antigène Voir toutes CILP Anticorps
    CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
    Épitope
    • 16
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reactivité
    • 26
    • 18
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Rat, Souris, Chien
    Hôte
    • 20
    • 4
    • 2
    • 2
    Chèvre
    Clonalité
    • 25
    • 3
    Polyclonal
    Conjugué
    • 12
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CILP est non-conjugé
    Application
    • 25
    • 14
    • 13
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody recognizes CILP.
    Réactivité croisée (Details)
    Species reactivity (expected):Human, Mouse and Canine (Dog).
    Species reactivity (tested):Rat.
    Purification
    Ammonium Sulphate Precipitation followed by antigen Affinity Chromatography using the immunizing peptide.
    Immunogène
    Peptide with sequence C-NYRRTDHEDPRVK, from the internal region of the protein sequence according to NP_003604.2.
    Top Product
    Discover our top product CILP Anticorps primaire
  • Indications d'application
    Peptide ELISA: Antibody Detection Limit Dilution: 1/128000. Western Blot: 0.1-0.3 μg/mL. Approx 150 kDa band observed in rat spinal cord lysates(calculated MW of 130 kDa according to human NP_003604.2 and of 130 kDa according toRat NP_001101631.1).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Tris saline, pH 7.3 containing 0.02 % Sodium Azide as preservative and 0.5 % BSA as stabilizer.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Antigène
    CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
    Autre désignation
    CILP1 (CILP Produits)
    Synonymes
    anticorps CILP-1, anticorps HsT18872, anticorps 9830114D16, anticorps C130036G17Rik, anticorps NTPPH, anticorps CILP, anticorps im:7137994, anticorps cartilage intermediate layer protein, anticorps cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, anticorps cartilage intermediate layer protein 1, anticorps CILP, anticorps Cilp, anticorps cilp, anticorps LOC100336614
    Sujet
    CILP, Cartilage Intermediate Layer Protein, is specifically expressed in the articular cartilage intermediate layer (it cannot be found in the superficial nor in the deepest layers) and is involved in scaffolding. Overexpression of this protein may lead to impairment of chondrocyte growth and matrix repair and indirectly promote inorganic pyrophosphate (PPi) supersaturation in aging and osteoarthritis cartilage. Antibodies against CILP are detected in patients with early-stage knee osteoarthritis and defects in this gene may be a cause of susceptibility to lumbar disk disease.Synonyms: CILP-1, Cartilage intermediate layer protein 1, Cartilage intermediate-layer protein
    ID gène
    8483
    NCBI Accession
    NP_003604
    UniProt
    O75339
Vous êtes ici:
Support technique